Association between hepatic fat and subclinical vascular disease burden in the general population
Open Access
- 30 September 2021
- journal article
- research article
- Published by BMJ in BMJ Open Gastroenterology
- Vol. 8 (1), e000709
- https://doi.org/10.1136/bmjgast-2021-000709
Abstract
Objective It is still controversial if increased hepatic fat independently contributes to cardiovascular risk. We aimed to assess the association between hepatic fat quantified by MRI and various subclinical vascular disease parameters. Design We included two cross-sectional investigations embedded in two independent population-based studies (Study of Health in Pomerania (SHIP): n=1341; Cooperative Health Research in the Region of Augsburg (KORA): n=386). The participants underwent a whole-body MRI examination. Hepatic fat content was quantified by proton-density fat fraction (PDFF). Aortic diameters in both studies and carotid plaque-related parameters in KORA were measured with MRI. In SHIP, carotid intima-media thickness (cIMT) and plaque were assessed by ultrasound. We used (ordered) logistic or linear regression to assess associations between hepatic fat and subclinical vascular disease. Results The prevalence of fatty liver disease (FLD) (PDFF >5.6%) was 35% in SHIP and 43% in KORA. In SHIP, hepatic fat was positively associated with ascending (β, 95% CI 0.06 (0.04 to 0.08)), descending (0.05 (0.04 to 0.07)) and infrarenal (0.02 (0.01 to 0.03)) aortic diameters, as well as with higher odds of plaque presence (OR, 95% CI 1.22 (1.05 to 1.42)) and greater cIMT (β, 95% CI 0.01 (0.004 to 0.02)) in the age-adjusted and sex-adjusted model. However, further adjustment for additional cardiometabolic risk factors, particularly body mass index, attenuated these associations. In KORA, no significant associations were found. Conclusions The relation between hepatic fat and subclinical vascular disease was not independent of overall adiposity. Given the close relation of FLD with cardiometabolic risk factors, people with FLD should still be prioritised for cardiovascular disease screening.Funding Information
- Deutsches Zentrum für Herz-Kreislaufforschung (81X2600209, 81X2600214)
- Bundesministerium für Bildung und Forschung (01ZZ0701, 01ZZ96030)
- Deutsche Forschungsgemeinschaft (BA 4233/4-1)
This publication has 43 references indexed in Scilit:
- Insulin Resistance, Hyperglycemia, and AtherosclerosisCell Metabolism, 2011
- Cohort Profile: The Study of Health in PomeraniaInternational Journal of Epidemiology, 2010
- Evaluation of diffuse liver steatosis by ultrasound, computed tomography, and magnetic resonance imaging: which modality is best?Clinical Imaging, 2009
- Hepatic Steatosis and Subclinical Cardiovascular Disease in a Cohort Enriched for Type 2 Diabetes: The Diabetes Heart StudyThe American Journal of Gastroenterology, 2008
- Identification and Characterization of Metabolically Benign Obesity in HumansArchives of Internal Medicine, 2008
- Burden and Prognostic Importance of Subclinical Cardiovascular Disease in Overweight and Obese IndividualsCirculation, 2007
- Mechanisms of Disease: hepatic steatosis in type 2 diabetes—pathogenesis and clinical relevanceNature Clinical Practice Endocrinology & Metabolism, 2006
- KORA - A Research Platform for Population Based Health ResearchDas Gesundheitswesen, 2005
- Empfehlungen zur Hochdruckbehandlung in der PraxisNotfall & Hausarztmedizin, 2005
- Quantitative Evaluation of Carotid Plaque Composition by In Vivo MRIArteriosclerosis, Thrombosis, and Vascular Biology, 2005